Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury — Stella

Home/Spinal Cord Injuries/

View on ClinicalTrials.gov

Recruiting

Back to Spinal Cord Injuries trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Semel Institute of Neuroscience at UCLA, Los Angeles, California

UCLA Clinical and Translational Research Center, Los Angeles, California

Key details

Sponsor

University of California, Los Angeles

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~12 participants

Started

September 2021

Primary completion

December 2027

Age range

18 Years – 75 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.